Results 91 to 100 of about 1,343 (178)
A method of comprehensive sequencing analysis of the small RNA fragmentome (RiboMarker)
Circulating cell-free nucleic acids (cfDNA and cfRNA) found in blood and other biofluids are promising biomarkers for cancer. However, current methods exploiting tumor-derived cfDNA (ctDNA) are not sensitive enough in detecting minimal residual disease and early stages of cancer when it is more treatable.
Rachel C. Clark +4 more
openaire +3 more sources
Cancer treatment monitoring using cell-free DNA fragmentomes
AbstractCirculating cell-free DNA (cfDNA) assays for monitoring individuals with cancer typically rely on prior identification of tumor-specific mutations. Here, we develop a tumor-independent and mutation-independent approach (DELFI-tumor fraction, DELFI-TF) using low-coverage whole genome sequencing to determine the cfDNA tumor fraction and validate ...
Iris van ’t Erve +21 more
openaire +4 more sources
Gastric cancer detection by stomach chromatin–anchored salivary cell-free DNA fragmentomics
The current liquid biopsy paradigm rests mostly on plasma cell-free DNA (cfDNA), and only to a limited extent on other biofluids. Saliva is molecularly rich but difficult to use, as tumour signal must be separated from abundant background noise. Salivary
M. Constanza Camargo +29 more
core +1 more source
Abstracts submitted to the ‘EACR 2026 Congress: Innovative Cancer Science’, from 08–11 June 2026 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley +1 more source
Multiple case-controlled studies have shown that analyzing fragmentation patterns in plasma cell-free DNA (cfDNA) can distinguish individuals with cancer from healthy controls.
Kinzler, KW +31 more
core +1 more source
Abstracts of 14th International Symposium on Hodgkin Lymphoma
HemaSphere, Volume 10, Issue S2, October 2026.
wiley +1 more source
A Pilot Study of Plasma Cell-Free DNA Fragmentomics in Gallbladder Cancer
Gallbladder cancer (GBC) is a rare and highly lethal biliary tract cancer with limited treatment options and lack of diagnostic and prognostic noninvasive biomarkers. Circulating cell-free DNA (cfDNA) offers a noninvasive means to capture fragmentomics alterations that may assist with diagnosis and biological characterization. This pilot study aimed to
Michael, Daniels +13 more
openaire +2 more sources
Genome-wide cfDNA fragmentation patterns in cerebrospinal fluid reflect medulloblastoma groups
Identifying molecular groups in medulloblastoma currently requires invasive biopsies for accurate diagnosis. We analyzed cerebrospinal fluid cell-free DNA (cfDNA) fragmentation patterns in 122 samples as a minimally-invasive alternative.
Alexander L Markowitz +6 more
doaj +1 more source
Multidimensional cell-free DNA fragmentomics enables early detection of breast cancer
Background Cell-free DNA (cfDNA) fragmentomics represents a transformative approach for early breast cancer detection, offering significant potential to improve patient survival through timely intervention.
Lixian Yang +9 more
doaj +1 more source

